ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 132 filers reported holding ANAPTYSBIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $232,027 | -31.5% | 10,663 | -2.4% | 0.00% | – |
| Q4 2022 | $338,658 | +22.7% | 10,928 | +0.7% | 0.00% | – |
| Q3 2022 | $276,000 | -29.8% | 10,848 | -44.1% | 0.00% | – |
| Q2 2022 | $393,000 | +3.4% | 19,402 | +26.2% | 0.00% | – |
| Q1 2022 | $380,000 | -49.6% | 15,373 | -29.2% | 0.00% | – |
| Q4 2021 | $754,000 | +222.2% | 21,700 | +423.4% | 0.00% | – |
| Q2 2019 | $234,000 | -50.6% | 4,146 | -36.1% | 0.00% | – |
| Q1 2019 | $474,000 | +115.5% | 6,491 | +88.2% | 0.00% | – |
| Q4 2018 | $220,000 | -69.3% | 3,449 | -52.0% | 0.00% | -100.0% |
| Q3 2018 | $717,000 | +192.7% | 7,189 | +108.4% | 0.00% | – |
| Q2 2018 | $245,000 | -61.5% | 3,450 | -43.6% | 0.00% | -100.0% |
| Q1 2018 | $637,000 | +90.7% | 6,112 | +84.2% | 0.00% | – |
| Q4 2017 | $334,000 | – | 3,319 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,950,609 | $35,032,938 | 4.94% |
| EcoR1 Capital, LLC | 7,521,024 | $135,077,591 | 4.56% |
| Saturn V Capital Management LP | 577,101 | $10,364,734 | 4.34% |
| GREAT POINT PARTNERS LLC | 894,333 | $16,062,221 | 2.93% |
| 5AM Venture Management, LLC | 357,733 | $6,424,885 | 1.85% |
| First Light Asset Management, LLC | 790,806 | $14,202,876 | 1.35% |
| Boxer Capital, LLC | 1,300,000 | $23,348,000 | 1.24% |
| Frazier Life Sciences Management, L.P. | 899,700 | $16,158,612 | 1.07% |
| Deep Track Capital, LP | 1,345,813 | $24,170,801 | 0.93% |
| Palo Alto Investors LP | 431,224 | $7,744,783 | 0.73% |